Several Florida Providers to Pay $3.5M Over False Billing Allegations

Several Pensacola, Fla.-based radiation oncology providers — including one health system — will pay a cumulative $3.5 million to resolve false billing allegations.

Advertisement

Sacred Heart Health System, West Florida Medical Center Clinic P.A., Emerald Coast Radiation Oncology Center, Gulf Region Radiation Oncology Centers and MSO and two physicians allegedly billed Medicare, Medicaid and Tricare for services that were ineligible for payment, according to the DOJ.

 

The government claimed the allegedly fraudulent billing occurred between 2007 and 2011, when the defendants billed for services that were not supervised by a physician.

The DOJ alleged the services were often performed while the defendant physicians were vacationing or working at another radiation oncology clinic. The providers also allegedly billed for services when patients’ medical records showed no evidence those services were rendered, according to the DOJ.

In addition to the monetary settlement, Gulf Region Radiation Oncology and the physicians entered into integrity agreements with the HHS Office of Inspector General.

Sacred Heart Health System, part of St. Louis-based Ascension Health, includes the 466-bed flagship Sacred Heart Hospital in Pensacola.

More Articles on Hospitals and Settlements:

33 Recent Investigations, Lawsuits and Settlements Involving Hospitals
Medicare Whistle-Blower Earns $2.1M in Settlement
Phoebe Putney Won’t Have to Sell Palmyra Hospital in FTC Settlement

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.